α7 Nicotinic receptor agonist-1
α7 Nicotinic receptor agonist-1 (Preparation 5) is an α7 nAChR agonist. α7 Nicotinic receptor agonist-1 can be used in studies of psychiatric disorders (such as schizophrenia, manic or hypomanic depression and anxiety disorders) and intellectual disorders (such as alzheimer's disease, learning deficits, cognitive deficits, attention deficits, memory loss, lewy body dementia and attention deficit hyperactivity disorder) [1].
Product Specifications
CAS Number
220100-05-0
UNSPSC
12352005
Target
NAChR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/α7-nicotinic-receptor-agonist-1.html
Purity
99.70
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
NC1=CN=C2OC3(CC2=C1)C(CC4)CCN4C3
Molecular Formula
C13H17N3O
Molecular Weight
231.29
References & Citations
[1]James Loch Iii, et al. Novel aralkyl amines of spirofuropyridines useful in therapy. Patent WO2000042044A1.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human IgG Immunoglobulin (IG266), CF647 conjugate, 0.1mg/mL
TYRP1 (Tyrosinase Related Protein 1) (TA99), CF640R conjugate, 0.1mg/mL
CD81 / TAPA-1 (1.3.3.22), CF740 conjugate, 0.1mg/mL
